These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12672249)

  • 21. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
    Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
    J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, structural evaluation, and estrogen receptor interaction of 2,3-diarylpiperazines.
    Gust R; Keilitz R; Schmidt K
    J Med Chem; 2002 May; 45(11):2325-37. PubMed ID: 12014971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
    Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
    Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
    Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
    Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
    J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
    Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells.
    von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W
    Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and investigations on the oxidative degradation of C3/C5-alkyl-1,2,4-triarylpyrroles as ligands for the estrogen receptor.
    Schäfer A; Wellner A; Gust R
    ChemMedChem; 2011 May; 6(5):794-803. PubMed ID: 21416612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor.
    Schmidt JM; Mercure J; Tremblay GB; Pagé M; Kalbakji A; Feher M; Dunn-Dufault R; Peter MG; Redden PR
    J Med Chem; 2003 Apr; 46(8):1408-18. PubMed ID: 12672240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
    Liu J; Sidell N
    Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
    Schertl S; Hartmann RW; Batzl-Hartmann C; Schlemmer R; Spruss T; Bernhardt G; Gust R; Schönenberger H
    Arch Pharm (Weinheim); 2001 Apr; 334(4):125-37. PubMed ID: 11382148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
    Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
    Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
    Zheng ZY; Lin VC
    Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homopterocarpanes as bridged triarylethylene analogues: synthesis and antagonistic effects in human MCF-7 breast cancer cells.
    Rampa A; Bisi A; Belluti F; Gobbi S; Piazzi L; Valenti P; Zampiron A; Caputo A; Varani K; Borea PA; Carrara M
    Farmaco; 2005 Feb; 60(2):135-47. PubMed ID: 15752472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
    Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
    J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
    Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
    J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer.
    Kumar S; Deshpande S; Chandra V; Kitchlu S; Dwivedi A; Nayak VL; Konwar R; Prabhakar YS; Sahu DP
    Bioorg Med Chem; 2009 Oct; 17(19):6832-40. PubMed ID: 19740667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.